| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |